<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T20:32:07+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2690】不负韶华，乘风破浪——2020年安罗替尼学术大盘点</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/PRY4NiIuF9My3RBryHrpRg</id>
    <link href="https://mp.weixin.qq.com/s/PRY4NiIuF9My3RBryHrpRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国首个自主研发上市的抗PD-1单抗 特瑞普利单抗注射液（拓益®）纳入国家医保目录</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/TPRP6nXcihlLJ-6A1fyrDw</id>
    <link href="https://mp.weixin.qq.com/s/TPRP6nXcihlLJ-6A1fyrDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“买4个疗程保终身”，医保之外，慈善赠药惠及更多肿瘤患者</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/U4DEQhUB9BYw0iiUfTqQxA</id>
    <link href="https://mp.weixin.qq.com/s/U4DEQhUB9BYw0iiUfTqQxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【完美收官】首届肿瘤诊疗黑科技大会—暨肿瘤诊疗黑科技年度TOP 20正式揭晓！</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/tgmkWMR8YyIgZzdvMPOb9g</id>
    <link href="https://mp.weixin.qq.com/s/tgmkWMR8YyIgZzdvMPOb9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020首届中国癌症防治年度大会在京召开，首批“人民好医生·金山茶花计划”获奖名单公布</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/1n6k0mUG8nziSFazfVZx8A</id>
    <link href="https://mp.weixin.qq.com/s/1n6k0mUG8nziSFazfVZx8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【8】探索OFS跌宕起伏的离奇经历之 SOFT-TEXT联合分析</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/kgc6l-wL3VpWitNisc4fcg</id>
    <link href="https://mp.weixin.qq.com/s/kgc6l-wL3VpWitNisc4fcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】新增17种抗肿瘤药，119种谈判成功，2020年国家医保药品目录正式公布</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/PP97FsJW4cN89Yz2XGTSLA</id>
    <link href="https://mp.weixin.qq.com/s/PP97FsJW4cN89Yz2XGTSLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【预告】“泌尿肿瘤免疫治疗系列沙龙”学术会议来袭，精彩不容错过！</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/TH4cbjStpzAcW0yh5H4wSQ</id>
    <link href="https://mp.weixin.qq.com/s/TH4cbjStpzAcW0yh5H4wSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2689】「重磅揭晓」2020年度TOP20肿瘤诊疗黑科技颁奖，于明晚18:30公布</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/o0RmWBuevQby-fT1mSJfDw</id>
    <link href="https://mp.weixin.qq.com/s/o0RmWBuevQby-fT1mSJfDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Adapting the EXTREME Regimen</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/tU3ttkBOEFLmMHlQnfWHTw</id>
    <link href="https://mp.weixin.qq.com/s/tU3ttkBOEFLmMHlQnfWHTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>伍钢教授：免疫治疗时代下广泛期小细胞肺癌放射治疗的机遇与挑战</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/ZJxkoH-yzs6pOqWDMUh7fQ</id>
    <link href="https://mp.weixin.qq.com/s/ZJxkoH-yzs6pOqWDMUh7fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杨坤禹教授：免疫治疗可进一步提高鼻咽癌治疗疗效，放免联合前景可期</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/ZvwrBWZ7cGTC1kxg6Lf1-A</id>
    <link href="https://mp.weixin.qq.com/s/ZvwrBWZ7cGTC1kxg6Lf1-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【7】探索OFS跌宕起伏的离奇经历之 SOFT（中位随访8年）研究解读</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/_lhkKBEpYKhK4C0YRUspFg</id>
    <link href="https://mp.weixin.qq.com/s/_lhkKBEpYKhK4C0YRUspFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2688】「2020金研奖」赵快乐教授：一个疗效和毒性恰当的方案对患者是非常重要的，我们须用一生去探索</title>
    <updated>2020-12-26T19:13:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/hg3CmOPBNmkJDEF3Co5-4A</id>
    <link href="https://mp.weixin.qq.com/s/hg3CmOPBNmkJDEF3Co5-4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧阳能太教授专访：谈二代测序（NGS）院内实验室建设原则及质量控制要点</title>
    <updated>2020-12-26T19:13:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/O-3jb9ohC1VQyX8a3WeNbQ</id>
    <link href="https://mp.weixin.qq.com/s/O-3jb9ohC1VQyX8a3WeNbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王俊杰教授谈放射治疗在前列腺癌中的应用现状与最新进展</title>
    <updated>2020-12-26T19:13:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/no6qqNVJfowtMk-cOO8r_w</id>
    <link href="https://mp.weixin.qq.com/s/no6qqNVJfowtMk-cOO8r_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>胡海教授专访：肿瘤自身抗体用于肺癌早诊与免疫治疗疗效预测，前景看好</title>
    <updated>2020-12-26T19:13:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/tf2HJFyeJFZQwojeQohAlw</id>
    <link href="https://mp.weixin.qq.com/s/tf2HJFyeJFZQwojeQohAlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议预热丨2020 CSCO《经典型骨肉瘤诊疗指南》巡讲—三亚站</title>
    <updated>2020-12-26T19:13:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/v-r3Fr-Uylv9Dscmp-0gPQ</id>
    <link href="https://mp.weixin.qq.com/s/v-r3Fr-Uylv9Dscmp-0gPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2687】【JCO】百家争鸣：ADAURA研究带来的反思</title>
    <updated>2020-12-25T18:55:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/QYzgRGTkV4jwOd9ThtGyUw</id>
    <link href="https://mp.weixin.qq.com/s/QYzgRGTkV4jwOd9ThtGyUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2021 ASCO-GI】12项研究入选口头报告，具体研究先睹为快！</title>
    <updated>2020-12-25T18:55:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/xJvWQZPbRxNfKeEKmWdp0g</id>
    <link href="https://mp.weixin.qq.com/s/xJvWQZPbRxNfKeEKmWdp0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>